GSK had their earnings call today. I didn't catch it yet but there was a Reuters article that mentioned that they hadn't given up on darapladib. http://www.reuters.com/article/2014/02/05/us-glaxosmithkline-earnings-setbacks-idUSBREA141HY20140205